Deferred Tax Assets, Valuation Allowance of ABBOTT LABORATORIES from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ABBOTT LABORATORIES quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • ABBOTT LABORATORIES Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $1,771,000,000, a 6.4% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ABBOTT LABORATORIES Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,771,000,000 +$107,000,000 +6.4% 31 Dec 2025 10-K 20 Feb 2026 2025 FY
Q4 2024 $1,664,000,000 -$7,026,000,000 -81% 31 Dec 2024 10-K 20 Feb 2026 2025 FY
Q4 2023 $8,690,000,000 +$7,521,000,000 +643% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q4 2022 $1,169,000,000 -$30,000,000 -2.5% 31 Dec 2022 10-K 16 Feb 2024 2023 FY
Q4 2021 $1,199,000,000 +$39,000,000 +3.4% 31 Dec 2021 10-K 17 Feb 2023 2022 FY
Q4 2020 $1,160,000,000 +$182,000,000 +19% 31 Dec 2020 10-K 18 Feb 2022 2021 FY
Q4 2019 $978,000,000 -$385,000,000 -28% 31 Dec 2019 10-K 19 Feb 2021 2020 FY
Q4 2018 $1,363,000,000 +$8,000,000 +0.59% 31 Dec 2018 10-K 21 Feb 2020 2019 FY
Q4 2017 $1,355,000,000 +$1,166,000,000 +617% 31 Dec 2017 10-K 22 Feb 2019 2018 FY
Q4 2016 $189,000,000 +$103,000,000 +120% 31 Dec 2016 10-K 16 Feb 2018 2017 FY
Q4 2015 $86,000,000 31 Dec 2015 10-K 17 Feb 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.